Henk Visscher

Henk Visscher

Princess Maxima Centre for Pediatric Oncology - / Netherlands
Others
AD Scientific Index ID: 652732
Prinses Maxima Centrum voor Kinderoncologie
person_outline Henk Visscher's MOST POPULAR ARTICLES
1-) Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children H Visscher, CJD Ross, SR Rassekh, A Barhdadi, MP Dubé, H Al-Saloos, ... Journal of clinical oncology 30 (13), 1422-1428, 2012 3852012
2-) Efflux and Atherosclerosis: The Clinical and Biochemical Impact of Variations in the ABCA1 GeneRR Singaraja, LR Brunham, H Visscher, JJP Kastelein, MR HaydenArteriosclerosis, thrombosis, and vascular biology 23 (8), 1322-1332, 20033662003
3-) Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapyCJD Ross, H Katzov-Eckert, MP Dubé, B Brooks, SR Rassekh, ...Nature genetics 41 (12), 1345-1349, 20093652009
4-) CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroupSC Warby, A Montpetit, AR Hayden, JB Carroll, SL Butland, H Visscher, ...The American Journal of Human Genetics 84 (3), 351-366, 20092992009
5-) A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancerF Aminkeng, AP Bhavsar, H Visscher, SR Rassekh, Y Li, JW Lee, ...Nature genetics 47 (9), 1079-1084, 20152722015